Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety
Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1021-1022
DOI: 10.1111/apt.70830 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 29.06.2026. Verfasst von Yousef Hakimi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Monash Health, Clayton, Victoria, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Monash Health, Clayton, Victoria, Australia.
- Department of Paediatrics, Monash University, Clayton, Victoria, Australia.
- Centre for Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
ORCID-Profile: Yousef Hakimi
Zitieren
APA
Hakimi, Y., & Giles, E. (2026). Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics, 64(7), 1021-1022. https://doi.org/10.1111/apt.70830
Vancouver
Hakimi Y, Giles E. Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics. 2026;64(7):1021-1022. doi:10.1111/apt.70830
BibTeX
@article{Hakimi2026,
author = {Hakimi, Yousef and Giles, Edward},
title = {Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {7},
pages = {1021--1022},
doi = {10.1111/apt.70830}
}
EUVIMED